Evidence map›Paper›PMID 36547142›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

Efficacy and Safety of the "Trisection Method" Training System for Robot-Assisted Radical Cystectomy at a Single Institution in Japan.

Keita Nakane, Toyohiro Yamada, Risa Tomioka-Inagawa, Fumiya Sugino, Naotaka Kumada, Makoto Kawase, Shinichi Takeuchi, Kota Kawase, Daiki Kato, Manabu Takai and 2 more

Open access · goldAbstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Keita NakaneDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.ORCID 0000-0002-2589-1722
Toyohiro YamadaDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Risa Tomioka-InagawaDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Fumiya SuginoDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Naotaka KumadaDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Makoto KawaseDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.ORCID 0000-0001-7269-2462
Shinichi TakeuchiDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Kota KawaseDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Daiki KatoDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.ORCID 0000-0003-4932-0497
Manabu TakaiDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Koji IinumaDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.ORCID 0000-0002-0362-8624
Takuya KoieDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.ORCID 0000-0002-2980-127X
Gifu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To maintain a surgeon's concentration, reduce fatigue, and train young surgeons, surgical procedures for bladder cancer are divided into the following parts: robot-assisted radical cystectomy (RARC), bowel reconstruction, and totally intracorporeal urinary diversion (ICUD) (RARC+ICUD). Each part is performed by a different surgeon (Trisection method). We retrospectively evaluated the efficacy and safety of this approach at a single institution in Japan. One hundred consecutive patients who underwent RARC+ICUD at Gifu University Hospital between November 2018 and August 2022 were included in this study. The patient background, surgical outcomes, and postoperative complications were compared between surgeries by first-, second-, and third-generation surgeons. The overall survival (OS) and recurrence-free survival (RFS) were compared between surgeries by each generation. Of the 100 patients, 19, 38, and 43 RARCs were performed by first-, second-, and third-generation surgeons, respectively. There were 35, 25, and 39 patients who underwent ileal conduit, neobladder, and ureterocutaneostomy, respectively. No significant differences were found among the patients respective to the type of ICUDs. Although the first-generation surgeon had a significantly shorter operative time with RARC, the surgical time for bowel reconstruction, length of hospital stays, and incidence of postoperative complications were not significantly different among the groups. Additionally, OS and RFS did not differ significantly among the generations. The "Trisection method" is an effective and safe concept with no difference in outcomes between the generations of surgeons.

Indexed as

RoboticsRobotic Surgical ProceduresCystectomyHumansJapanPostoperative ComplicationsRetrospective StudiesTreatment Outcomebladder canceroncological outcomesrobot-assisted radical cystectomysurgical outcomessurgical training system

Identifiers

PMID36547142
PMCPMC9776992
OpenAlexW4310988827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.